|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 31/40 | |||
| A61K 31/401 | |||
| A61K 45/06 | |||
| A61K 9/20 | |||
| A61K 47/40 |
| (11) | Number of the document | 3082773 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14820814.3 |
| Date of filing the European patent application | 2014-12-15 | |
| (97) | Date of publication of the European application | 2016-10-26 |
| (45) | Date of publication and mention of the grant of the patent | 2017-10-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/077767 |
| Date | 2014-12-15 |
| (87) | Number | WO 2015/091365 |
| Date | 2015-06-25 |
| (30) | Number | Date | Country code |
| 13197606 | 2013-12-17 | EP |
| (72) |
CHOLLET, Andre, CH
POHL, Olivier, CH
|
| (73) |
ObsEva S.A.,
12, Chemin des Aulx, 1228 Plan-les-Ouates/Geneve,
CH
|
| (54) | ORAL FORMULATIONS OF PYRROLIDINE DERIVATIVES |
| ORAL FORMULATIONS OF PYRROLIDINE DERIVATIVES |